Companies / Corcept Therapeutics Inc / Activity
Activity — Corcept Therapeutics Inc
130 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Mokari Atabak Executive | Exercise | Stock option (right to buy) | — | -40K -40.00% | 60,000 0.06% of shares | low |
| May 27, 2026 | Maduck Sean Executive | Exercise | Stock option (right to buy) | — | -75K -30.99% | 166,986 0.15% of shares | low |
| May 21, 2026 | Baker G Leonard Jr Director | Grant | Stock Option (Right To Buy) | — | +13K | 12,500 0.01% of shares | low |
| May 21, 2026 | Alton Gregg H Director | Grant | Stock Option (right to buy) | — | +13K | 12,500 0.01% of shares | low |
| May 21, 2026 | Wilson James N Director | Grant | Stock Option (right to buy) | — | +13K | 12,500 0.01% of shares | low |
| May 21, 2026 | Swisher Daniel N JR Director | Grant | Stock Option (right to buy) | — | +13K | 12,500 0.01% of shares | low |
| May 21, 2026 | Murray Joshua M. Director | Grant | Stock Option (right to buy) | — | +13K | 12,500 0.01% of shares | low |
| May 21, 2026 | Mahoney David L Director | Grant | Stock Option (right to buy) | — | +13K | 12,500 0.01% of shares | low |
| May 21, 2026 | Park Kimberly Director | Grant | Stock Option (right to buy) | — | +13K | 12,500 0.01% of shares | low |
| May 5, 2026 | Guyer William Executive | Exercise | Stock Option (right to buy) | — | -20K -10.53% | 170,000 0.16% of shares | low |
| Apr 7, 2026 | Guyer William Executive | Exercise | Stock Option (right to buy) | — | -20K -9.52% | 190,000 0.18% of shares | low |
| Feb 27, 2026 | Lyon Joseph Douglas Executive | Grant | Stock Option (right to buy) | — | +140K | 140,000 0.13% of shares | low |
| Feb 27, 2026 | Maduck Sean Executive | Grant | Stock Option (right to buy) | — | +140K | 140,000 0.13% of shares | low |
| Feb 27, 2026 | Hunt Hazel Executive | Grant | Stock Option (right to buy) | — | +140K | 140,000 0.13% of shares | low |
| Feb 9, 2026 | Hunt Hazel Executive | Exercise | Stock Option (right to buy) | — | -150K -100.00% | 0 0.00% of shares | low |
| Feb 27, 2026 | Mokari Atabak Executive | Grant | Stock Option (right to buy) | — | +140K | 140,000 0.13% of shares | low |
| Feb 27, 2026 | Robb Gary Charles Executive | Grant | Stock Option (right to buy) | — | +140K | 140,000 0.13% of shares | low |
| Feb 27, 2026 | Belanoff Joseph K CEO | Grant | Stock Option (right to buy) | — | +460K | 460,000 0.43% of shares | low |
| Feb 24, 2026 | Wilson James N Director | Exercise | Stock option (right to buy) | — | +100K | 0 0.00% of shares | low |
| Mar 13, 2026 | Mahoney David L Director | Exercise | Stock Option (right to buy) | — | -30K -100.00% | 0 0.00% of shares | low |
| Jan 27, 2026 | Baker G Leonard Jr Director | Exercise | Stock Option (Right To Buy) | — | -30K -100.00% | 0 0.00% of shares | low |
| Jan 27, 2026 | Baker G Leonard Jr Director | Exercise | Stock Option (Right To Buy) | — | -25K -100.00% | 0 0.00% of shares | low |
| Jan 27, 2026 | Baker G Leonard Jr Director | Exercise | Stock Option (Right To Buy) | — | -25K -100.00% | 0 0.00% of shares | low |
| Jan 27, 2026 | Baker G Leonard Jr Director | Exercise | Stock Option (Right To Buy) | — | -30K -100.00% | 0 0.00% of shares | low |
| Jan 27, 2026 | Baker G Leonard Jr Director | Exercise | Stock Option (Right To Buy) | — | -30K -100.00% | 0 0.00% of shares | low |
| Mar 20, 2026 | Guyer William Executive | Exercise | Stock Option (right to buy) | — | -12K -5.31% | 210,000 0.19% of shares | low |
| Mar 4, 2026 | Guyer William Executive | Exercise | Stock Option (right to buy) | — | -8K -3.58% | 221,767 0.21% of shares | low |
| Feb 27, 2026 | Guyer William Executive | Grant | Stock Option (right to buy) | — | +140K | 140,000 0.13% of shares | low |
| Feb 3, 2026 | Guyer William Executive | Exercise | Stock option (right to buy) | — | -20K -8.00% | 230,000 0.21% of shares | low |
| Jan 6, 2026 | Guyer William Executive | Exercise | Stock option (right to buy) | — | -20K -7.41% | 250,000 0.23% of shares | low |